Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
merck
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
4
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
adverum biotechnologies
biogen
biotech
bristol-myers squibb
cancer
diagnostics
drugs
gene therapy
glaxosmithkline
ifm therapeutics
What
drug
4
×
bio
roundup
cancer
new
patients
pricing
acquisitions
advanced
advantages
albert
approved
arrival
award
bar
biggest
bourla
brings
ceo
company
crispr
data
death
decades
deeper
dems
dna
expect
fda
fingerprint
future
gamble
genetic
given
going
immunotherapy
imports
longer
lung
maker
Language
unset
unknown
Current search:
roche
×
drug
×
merck
×
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
